CellaVision AB
OTC:CLVSF

Watchlist Manager
CellaVision AB Logo
CellaVision AB
OTC:CLVSF
Watchlist
Price: 20.24 USD Market Closed
Updated: May 18, 2024

CellaVision AB
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

CellaVision AB
Revenue Peer Comparison

Comparables:
EKTA B
GETI B
ARJO B
ELOS B
SEDANA

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
CellaVision AB
STO:CEVI
Revenue
kr708.3m
CAGR 3-Years
15%
CAGR 5-Years
13%
CAGR 10-Years
14%
Elekta AB (publ)
STO:EKTA B
Revenue
kr16.9B
CAGR 3-Years
5%
CAGR 5-Years
8%
CAGR 10-Years
N/A
Getinge AB
STO:GETI B
Revenue
kr31.8B
CAGR 3-Years
2%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Arjo AB (publ)
STO:ARJO B
Revenue
kr11B
CAGR 3-Years
7%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Elos Medtech AB
STO:ELOS B
Revenue
kr888.5m
CAGR 3-Years
9%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Sedana Medical AB (publ)
STO:SEDANA
Revenue
kr164.9m
CAGR 3-Years
3%
CAGR 5-Years
22%
CAGR 10-Years
N/A

See Also

What is CellaVision AB's Revenue?
Revenue
708.3m SEK

Based on the financial report for Mar 31, 2024, CellaVision AB's Revenue amounts to 708.3m SEK.

What is CellaVision AB's Revenue growth rate?
Revenue CAGR 10Y
14%

Over the last year, the Revenue growth was 15%. The average annual Revenue growth rates for CellaVision AB have been 15% over the past three years , 13% over the past five years , and 14% over the past ten years .